Edition:
United Kingdom

Dynavax Technologies Corp (DVAX.OQ)

DVAX.OQ on NASDAQ Stock Exchange Capital Market

4.33USD
19 Aug 2019
Change (% chg)

$0.34 (+8.52%)
Prev Close
$3.99
Open
$4.04
Day's High
$4.36
Day's Low
$4.04
Volume
538,657
Avg. Vol
399,094
52-wk High
$14.30
52-wk Low
$2.60

About

Dynavax Technologies Corporation is a clinical-stage immunotherapy company. The Company is focused on leveraging the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $1,380.17
Shares Outstanding(Mil.): 59.75
Dividend: --
Yield (%): --

Financials

  DVAX.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -2.48 -- --
ROI: -72.82 8.94 14.48
ROE: -73.07 10.07 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates